Correction: Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
Metrics: PDF 1630 views | ?
1 Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
2 Grade 2013, School of Stomatology, Nanchang University, Nanchang, China
3 Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
4 Grade 2013, The Second Clinical Medical College of Nanchang University, Nanchang, China
* Co-first authors contributted equally to this work
Published: January 15, 2018
This article has been corrected: Dr. Fu and Dr. Xu citations have been changed to affiliation 1 and affiliation 5 is now deleted.
Original article: Oncotarget. 2017; 8:89364-89374. DOI: https://doi.org/10.18632/oncotarget.19382.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.